Related Experiment Videos
Autoimmune aspects of vitiligo
E H Kemp1, E A Waterman, A P Weetman
1Division of Clinical Sciences, Northern General Hospital, University of Sheffield, UK. e.h.kemp@sheffield.ac.uk
Autoimmunity
|October 30, 2001
Summary
Vitiligo, a skin depigmentation disorder, is strongly linked to autoimmune processes. Evidence suggests immune cells and antibodies targeting melanocytes contribute to vitiligo development.
Area of Science:
- Dermatology
- Immunology
- Autoimmune Disorders
Background:
- Vitiligo is a depigmenting disorder involving melanocyte loss.
- The precise cause of vitiligo is unknown, but an autoimmune basis is suspected.
- Vitiligo often co-occurs with other autoimmune conditions.
Purpose of the Study:
- To review the evidence supporting an autoimmune aetiology for vitiligo.
- To discuss observations linking vitiligo to immune system dysregulation.
Main Methods:
- Review of clinical observations and scientific literature.
- Analysis of associations between vitiligo and other autoimmune diseases.
- Examination of immunological markers in vitiligo patients.
- Consideration of therapeutic responses and animal models.
Main Results:
- Vitiligo frequently associates with autoimmune disorders like thyroiditis and diabetes mellitus.
- Circulating antibodies and T lymphocytes reactive to melanocyte antigens are found in vitiligo patients.
- Immunosuppressive therapies show effectiveness in treating vitiligo.
- Association with Major Histocompatibility Complex (MHC) antigens supports an immune role.
Conclusions:
- Strong evidence supports an autoimmune aetiology for vitiligo.
- Immune mechanisms, including T-cell and antibody responses against melanocytes, are implicated in vitiligo pathogenesis.
- Further research into the immune basis of vitiligo is warranted.